首页> 外文期刊>Cancer biology & therapy >PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1
【24h】

PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1

机译:PRKCZ-AS1通过海绵MIR-766-5P促进肺腺癌的肿瘤引发,以调节MAPK1

获取原文
获取原文并翻译 | 示例
       

摘要

Lung adenocarcinoma (LUAD) is the most prevalent histological subclass of non-small cell lung cancer. Long non-coding RNAs (lncRNAs) have been recognized as the crucial regulatory factors in tumor development and progression. Nevertheless, limited research has been carried on the function of PRKCZ-AS1 in LUAD. In this study, the expression of PRKCZ-AS1 in LUAD tissues and cell lines was notably upregulated. Moreover, knockdown of PRKCZ-AS1 inhibited the proliferation and migration, but promoted apoptosis in LUAD cells. Furthermore, miR-766-5p could bind with PRKCZ-AS1. Besides, the expression miR-766-5p was negatively regulated by PRKCZ-AS1 expression in LUAD cells. Furtherly, PRKCZ-AS1 expression positively regulated the expression of MAPK1. Similarly, the expression of MAPK1 was negatively regulated by miR-766-5p expression. Moreover, the binding ability between miR-766-5p and MAPK1 was confirmed. Furthermore, knockdown of MAPK1 partly rescued the miR-766-5p inhibition-mediated promoting effect on proliferation and migration in LUAD cells transfected with PRKCZ-AS1#1. Overall, above results suggested that PRKCZ-AS1 promotes the occurrence of LUAD by sponging miR-766-5p to upregulate MAPK1 expression, which may provide new insights into LUAD treatment.
机译:肺腺癌(Luad)是非小细胞肺癌中最普遍的组织学组织亚类。长期非编码RNA(LNCRNA)被认为是肿瘤发展和进展的关键调节因子。尽管如此,有限的研究已经采用了普拉德的PRKCZ-AS1的功能。在该研究中,显着上调了管道组织和细胞系中Prkcz-AS1的表达。此外,PRKCZ-AS1的敲低抑制了扩散和迁移,但促进了管道细胞的细胞凋亡。此外,MiR-766-5P可以与PRKCZ-AS1结合。此外,通过路障细胞的PRKCZ-AS1表达对表达MIR-766-5P产生负调节。此外,PRKCZ-AS1表达积极地调节MAPK1的表达。类似地,MAPK1的表达由miR-766-5p表达负调节。此外,确认了miR-766-5P和MAPK1之间的结合能力。此外,MAPK1的敲低部分地拯救了用PRKCZ-AS1#1转染的路障细胞增殖和迁移的miR-766-5p抑制介导的促进作用。总体而言,上述结果表明,PRKCZ-AS1通过海绵MIR-766-5P提升MAPK1表达,促进了拉德的发生,这可能对路德治疗提供新的见解。

著录项

  • 来源
    《Cancer biology & therapy》 |2020年第6期|共8页
  • 作者

    Wang Ming; Liao Qin; Zou Pengfei;

  • 作者单位

    Shulan Hangzhou Hosp Dept Thorac Surg Hangzhou Zhejiang Peoples R China;

    Shulan Hangzhou Hosp Dept Oncol Hangzhou 310000 Zhejiang Peoples R China;

    Shulan Hangzhou Hosp Dept Infect Dis Hangzhou Zhejiang Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    LUAD; PRKCZ-AS1; miR-766-5p; MAPK1;

    机译:粘土;PRKCZ-AS1;MIR-766-5P;MAPK1;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号